Research and development activities are expanding again for Novartis Animal Health in the production facility near Larchwood, Iowa, where all licensed vaccine production now takes place. Novartis will be doing a $6,000,000 expansion in the Larchwood facility.
Novartis Animal Health K.K. is fully owned subsidiary of Novartis Holding Japan K.K., which was established in July 2000. Novartis Animal Health and its predecessor companies have been present in the Japanese animal health market for more than 25 year.
Novartis Animal Health researches, develops and commercializes leading animal treatments that meet the needs of pet owners, farmers and veterinarians. Headquarters are in Basel, Switzerland, and present in almost 40 countries.
